Drug intelligence / Profile preview

Yanggan Yizhong Formula

Development stage: Unknown
Lead developer: Shanghai Yizhong Pharmaceutical
Administration: Oral

Overview

Yanggan Yizhong Formula is a traditional Chinese medicine (TCM) herbal combination used as an adjunctive therapy in the treatment of advanced gastric cancer. It is administered alongside standard treatments to improve survival outcomes in patients with advanced stages of this disease. The formula consists of multiple herbs, though the exact composition is not specified in the available sources. Its mechanism of action likely involves immunomodulation, anti-inflammatory effects, and support for organ function, consistent with TCM principles. Clinical trials are ongoing to evaluate its efficacy and safety when combined with conventional therapies[1][3].

Brand names: Yanggan Yizhong Formula
Other names: Anti-cancer formula II

Beyond the preview

Go deeper on Yanggan Yizhong Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yanggan Yizhong Formula.

Explore the full profile